{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:15:47Z","timestamp":1792671347159,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110052","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:26:43Z","timestamp":1779899203000},"page":"110052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rationally designed quinazolinone derivatives incorporating acetyl pyridine and thiazole scaffolds as dual EGFR\/HER-2 anticancer agents: integrated biological evaluation, molecular profiling, and advanced computational studies"],"prefix":"10.1016","volume":"179","author":[{"given":"Hagar S.","family":"El-Hema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.-S.","family":"El-Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Hawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman S.","family":"Nossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modather F.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T.","family":"Elhendawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.-H.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110052_bb0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1470-2045(25)00730-2","article-title":"Global, regional, and national burden of breast cancer among females, 1990\u20132023, with forecasts to 2050: a systematic analysis for the global burden of disease study 2023","volume":"27","author":"Bhangdia","year":"2026","journal-title":"Lancet Oncol."},{"issue":"2025","key":"10.1016\/j.bioorg.2026.110052_bb0010","first-page":"1565","article-title":"Cancer Collaborators, The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis","volume":"406","author":"GBD","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110052_bb0015","doi-asserted-by":"crossref","first-page":"04155","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynaecological cancers in 2022 and projections to 2050","volume":"14","author":"Zhu","year":"2024","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.bioorg.2026.110052_bb0020","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41598-021-81563-3","article-title":"Depletion of survivin suppresses docetaxel-induced apoptosis in HeLa cells by facilitating mitotic slippage","volume":"11","author":"Han","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110052_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200238","article-title":"Cervical cancer therapies: current challenges and future perspectives","volume":"13","author":"Burmeister","year":"2022","journal-title":"Tumour Virus Res."},{"key":"10.1016\/j.bioorg.2026.110052_bb0030","doi-asserted-by":"crossref","first-page":"1405491","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.110052_bb0035","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110052_bb0040","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bioorg.2026.110052_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176013","article-title":"Cancer chemotherapy resistance: mechanisms and recent breakthrough in targeted drug delivery","volume":"958","author":"Davodabadi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110052_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bioorg.2026.110052_bb0055","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/cancers14071614","article-title":"Molecular mechanisms of cancer drug resistance: emerging biomarkers and promising targets","volume":"14","author":"Fontana","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110052_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.446","article-title":"Receptor tyrosine kinases: biological functions and anticancer targeted therapy","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.110052_bb0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110052_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.110052_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","article-title":"Role of epidermal growth factor receptor in breast cancer","volume":"136","author":"Masuda","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bioorg.2026.110052_bb0080","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: a model for targeted therapy","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110052_bb0085","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","article-title":"The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110052_bb0090","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110052_bb0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.110052_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/B978-0-12-381298-8.00027-7","article-title":"Measurement of constitutive MAPK and PI3K\/AKT signaling activity in human cancer cell lines","volume":"484","author":"Paraiso","year":"2010","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bioorg.2026.110052_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110052_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110052_bb0115","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1038\/s41598-024-52897-5","article-title":"Dual anti-HER2\/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC","volume":"14","author":"Song","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110052_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101078","article-title":"Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models","volume":"74","author":"Yang","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2026.110052_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110052_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257976","article-title":"Prevalence of HER2 overexpression and amplification in cervical cancer: a systematic review and meta-analysis","volume":"16","author":"Itkin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110052_bb0135","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3390\/ijms27073018","article-title":"From synthesis to mechanism: Biological evaluation of p-toluidine-based thiazolidinone-quinoline VEGFR-2 candidate supported by CADD","volume":"27","author":"Manni","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110052_bb0140","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/ijms27052445","article-title":"Design and multi-level biological evaluation of naphthyridine-based derivatives as topoisomerase I\/II-targeted anticancer agents with anti-fowlpox virus activity supported by in silico analysis","volume":"27","author":"El-Hema","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110052_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.145685","article-title":"Thienyl-based pyrimidine hybrids as multi-target anticancer agents: design, synthesis, and integrated experimental-computational insights into CDK4 inhibition and apoptosis","volume":"1361","author":"Hussein","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.145461","article-title":"From benzo[g]quinoline multitargeted anticancer scaffold to a potent benzo[g]pyrimido[4,5-b]quinoline lead targeting wild-type and mutant EGFR: insights from integrated computational studies, molecular signaling modulation, and gene expression networks","volume":"1359","author":"El-Hema","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.146452","article-title":"Hybridization-driven design of triazole-imidazol-4(5H)-one conjugates as multi-target cholinesterase and inflammatory enzyme inhibitors: Synthesis, biological evaluation, and comprehensive computational studies","author":"El-Hema","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/pharmaceutics18040424","article-title":"A multi-target nitrogen-fused azole drug platform derived from a pyrazoline-thiadiazole moiety: In vivo antimicrobial validation and comprehensive anticancer investigation supported by computational studies","volume":"18","author":"El-Hema","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110052_bb0165","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/ph18101472","article-title":"Innovative amino-functionalization of pyrido[2,3-d]pyrimidine scaffolds for broad therapeutic applications supported by computational analyses","volume":"18","author":"El-Hema","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110052_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143790","article-title":"Novel pyrimidopyridothiazine based derivatives as potential anticancer and antibacterial agents: a step towards design and synthesis of multi-targeted therapeutics","volume":"1349","author":"El-Hema","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0175","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1021\/acsomega.4c11076","article-title":"Design, characterization, antimicrobial activity, and in silico studies of theinothiazoloquinazoline derivatives bearing thiazinone, tetrazole, and triazole moieties","volume":"10","author":"El-Hema","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110052_bb0180","doi-asserted-by":"crossref","first-page":"27992","DOI":"10.1038\/s41598-025-12140-1","article-title":"Design, antiproliferative potency, and in silico studies of novel (5-methylfuran-3-yl)thio-3-phenylquinazolin-4(3H)-one derivatives as potential EGFR inhibitors","volume":"15","author":"Soliman","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110052_bb0185","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.clinthera.2009.11.029","article-title":"Lapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer","volume":"31","author":"Tevaarwerk","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bioorg.2026.110052_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128703","article-title":"Synthesis and biological evaluation of new series of quinazoline derivatives as EGFR\/HER2 dual-target inhibitors","volume":"67","author":"Jiao","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110052_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107686","article-title":"Design, synthesis and biological evaluation of novel quinazoline-derived EGFR\/HER2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents","volume":"151","author":"Hao","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0200","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bioorg.2018.07.015","article-title":"Dual EGFR\/HER2 inhibitors and apoptosis inducers: new benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers","volume":"80","author":"Ghorab","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109476","article-title":"Expanding the chemical and therapeutic landscape of 5H-indeno[1,2-b]pyridin-5-one derivatives: novel anticancer activity, EGFR inhibition, and modulation of HIF\u2013VEGF and PI3K\/AKT\/mTOR pathways supported by computational insights","volume":"170","author":"El-Hema","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106874","article-title":"New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: synthesis, anticancer evaluation, and molecular modeling studies","volume":"141","author":"Hawas","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0215","doi-asserted-by":"crossref","first-page":"2152810","DOI":"10.1080\/14756366.2022.2152810","article-title":"Discovery of new pyridine-quinoline hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase-3\/7 activation capabilities","volume":"38","author":"El-Miligy","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100454","article-title":"Upregulation of BAX and caspase-3, as well as downregulation of Bcl-2 during apoptosis in human cancer cells","volume":"355","author":"Fayed","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110052_bb0225","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/molecules29040875","article-title":"Recent advances in structural optimization of quinazoline-based protein kinase inhibitors for cancer therapy (2021\u2013present)","volume":"29","author":"Abdel-Mohsen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110052_bb0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molcel.2023.11.040","article-title":"The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death","volume":"84","author":"Ai","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.110052_bb0235","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","article-title":"Caspases as master regulators of programmed cell death: apoptosis, pyroptosis and beyond","volume":"57","author":"Dho","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110052_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106099","article-title":"Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors","volume":"128","author":"Farouk","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0245","first-page":"178","article-title":"Synthesis and antimicrobial evaluation of 2-thioxoimidazolidinone derivatives","volume":"17","author":"Mallikarjunaswamy","year":"2024","journal-title":"Org. Commun."},{"key":"10.1016\/j.bioorg.2026.110052_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.107209","article-title":"Computational and experimental insights into pharmacological potential: Synthesis, in vitro evaluation, and molecular docking analysis of bioactive urea and thiourea derivatives","volume":"200","author":"Babu","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2026.110052_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12272-022-01376-4","article-title":"Structure\u2013activity relationships of novel quinazoline derivatives with high selectivity for HER2 over EGFR","volume":"45","author":"Lee","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2026.110052_bb0260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acsapm.9b01051","article-title":"Temperature-responsive multilayer films of micelle-based composites for controlled release of a third-generation EGFR inhibitor","volume":"2","author":"Xu","year":"2020","journal-title":"ACS Appl. Polym. Mater."},{"key":"10.1016\/j.bioorg.2026.110052_bb0265","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1021\/acsanm.1c03334","article-title":"Temperature-responsive multilayer films based on block copolymer-coated silica nanoparticles for long-term release of favipiravir","volume":"4","author":"Xu","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bioorg.2026.110052_bb0270","doi-asserted-by":"crossref","first-page":"30321","DOI":"10.1021\/acsomega.2c03591","article-title":"Steric effects in the deposition mode and drug-delivering efficiency of nanocapsule-based multilayer films","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110052_bb0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13233-024-00246-w","article-title":"Energy storage enabled by cross-linked multilayer films using block copolymer-modified nanocapsules and chitosan biopolymers","volume":"32","author":"Xu","year":"2024","journal-title":"Macromol. Res."},{"key":"10.1016\/j.bioorg.2026.110052_bb0280","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad2a3b","article-title":"Stimuli-triggered multilayer films in response to temperature and ionic strength changes for controlled favipiravir drug release","volume":"19","author":"Xu","year":"2024","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.bioorg.2026.110052_bb0285","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1039\/D4AN01586J","article-title":"One-pot synthesized three-way junction based multiple strand displacement amplification for sensitive assay of H5N1 DNA","volume":"150","author":"Wu","year":"2025","journal-title":"Analyst"},{"key":"10.1016\/j.bioorg.2026.110052_bb0290","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.1039\/D6RA00253F","article-title":"Development, anti-proliferative activity, multi-target kinase inhibition against CHK1, PIM1, and CDK-2, and computational insights of new thiazole-based hybrids","volume":"16","author":"Altwaijry","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110052_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142953","article-title":"New quinazolinone-based heterocyclic compounds as promising antimicrobial agents: Development, DNA gyrase B\/topoisomerase IV inhibition activity, and in silico computational studies","volume":"1344","author":"Alsfouk","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0300","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1039\/D4RA06744D","article-title":"Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38\u03b1 MAPK kinase inhibitory effects","volume":"15","author":"Alsfouk","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110052_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105964","article-title":"New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors","volume":"127","author":"Alamshany","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133926","article-title":"Chemical synthesis and molecular docking study of new thiazole, thiophene, and thieno[2,3-d]pyrimidine derivatives as potential antiproliferative and antimicrobial agents","volume":"1270","author":"Othman","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0315","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/molecules25051096","article-title":"Chiral pyridine-3,5-bis-(L-phenylalaninyl-L-leucinyl) Schiff base peptides as potential anticancer agents: Design, synthesis, and molecular docking studies targeting lactate dehydrogenase-A","volume":"25","author":"Amr","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110052_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134130","article-title":"Design, synthesis and molecular docking simulation of oxindole-based derivatives with dual VEGFR-2 and cholinesterase inhibitory activities","volume":"1271","author":"Srour","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110052_bb0325","doi-asserted-by":"crossref","first-page":"39250","DOI":"10.1021\/acsomega.3c04736","article-title":"New thiophenyl-pyrazolyl-thiazole hybrids as DHFR inhibitors: Design, synthesis, antimicrobial evaluation, molecular modeling, and biodistribution studies","volume":"8","author":"Dawood","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110052_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/open.202500411","article-title":"Photophysical and DNA-binding properties of phenoxazine-based push\u2013pull type organic chromophores: Insights from DFT, molecular docking, and optical studies","volume":"15","author":"Naik","year":"2026","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.bioorg.2026.110052_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/cptc.202500318","article-title":"Thiophene-based fluoranthene derivatives: Study on their charge transfer and aggregation behavior","volume":"10","author":"Debnath","year":"2026","journal-title":"ChemPhotoChem"},{"key":"10.1016\/j.bioorg.2026.110052_bb0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110052_bb0345","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2026.110052_bb0350","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110052_bb0355","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","article-title":"The limited in vitro lifetime of human diploid cell strains","volume":"37","author":"Hayflick","year":"1965","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bioorg.2026.110052_bb0360","series-title":"EGFR Kinase Assay Kit, Cat. No. 40321","author":"BPS Bioscience","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110052_bb0365","series-title":"HER2 Kinase Assay Kit, Cat. No. 40721","author":"BPS Bioscience","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110052_bb0370","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110052_bb0375","first-page":"2597","article-title":"Modified annexin V\/propidium iodide apoptosis assay for accurate assessment of cell death","volume":"50","author":"Rieger","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioorg.2026.110052_bb0380","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110052_bb0385","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110052_bb0390","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2026.110052_bb0395","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110052_bb0400","series-title":"Human BAX ELISA Kit (EIA-4487)","author":"DRG International","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110052_bb0405","series-title":"Human Active Caspase-3 ELISA Kit","author":"Thermo Fisher Scientific (Invitrogen)","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110052_bb0410","series-title":"MyBioSource, Human CCND1 (Cyclin D1) ELISA Kit","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110052_bb0415","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110052_bb0420","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110052_bb0425","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0430","doi-asserted-by":"crossref","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","article-title":"Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein","volume":"286","author":"Aertgeerts","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110052_bb0435","series-title":"Molecular Operating Environment (MOE), version 2024.0601","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110052_bb0440","series-title":"Proc. 2006 ACM\/IEEE Conf. on Supercomputing","first-page":"84","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110052_bb0445","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1085\/jgp.200910373","article-title":"Exploring atomic resolution physiology on a femtosecond to millisecond timescale using molecular dynamics simulations","volume":"135","author":"Dror","year":"2010","journal-title":"J. Gen. Physiol."},{"issue":"32","key":"10.1016\/j.bioorg.2026.110052_bb0450","doi-asserted-by":"crossref","first-page":"13118","DOI":"10.1073\/pnas.1104614108","article-title":"Pathway and mechanism of drug binding to G-protein-coupled receptors","volume":"108","author":"Dror","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"45","key":"10.1016\/j.bioorg.2026.110052_bb0455","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110052_bb0460","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2026.110052_bb0465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/wcms.81","article-title":"The ORCA program system","volume":"2","author":"Neese","year":"2012","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110052_bb0470","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2026.110052_bb0475","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1021\/ja100936w","article-title":"Revealing noncovalent interactions","volume":"132","author":"Johnson","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110052_bb0480","series-title":"Molecular electrostatic potentials: concepts and applications","year":"1996"},{"key":"10.1016\/j.bioorg.2026.110052_bb0485","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/cr990029p","article-title":"Conceptual density functional theory","volume":"103","author":"Geerlings","year":"2003","journal-title":"Chem. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:29:38Z","timestamp":1780993778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":97,"alternative-id":["S0045206826005882"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110052","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationally designed quinazolinone derivatives incorporating acetyl pyridine and thiazole scaffolds as dual EGFR\/HER-2 anticancer agents: integrated biological evaluation, molecular profiling, and advanced computational studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110052"}}